Schrödinger, Inc. (SDGR)
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.82 per share a year ago.
Schrodinger Inc (SDGR) Shares Fall 4.1% -- What GF Score of 69 Tells Investors
On April 22, 2026, Schrodinger Inc (SDGR) shares fell 4.1% today, bringing the current price to $12.35. The stock has experienced a 52-week range between $10.95
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript
Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript
Wall Street Analysts Believe Schrodinger (SDGR) Could Rally 46.17%: Here's is How to Trade
The consensus price target hints at a 46.2% upside potential for Schrodinger (SDGR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now
Schrodinger (SDGR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Schrödinger, Inc. (SDGR) Q3 2025 Earnings Call Transcript
Schrödinger, Inc. ( SDGR ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Jaren Madden - Chief Corporate Affairs Officer & Head of Investor Relations Ramy Farid - CEO, President & Director Richie Jain - Executive VP, CFO & Treasurer Karen Akinsanya - President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships Conference Call Participants Mani Foroohar - Leerink Partners LLC, Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division Conor MacKay - BMO Capital Markets Equity Research Dennis Ding Brendan Smith - TD Cowen, Research Division Michael Ryskin - BofA Securities, Research Division Presentation Operator Thank you for standing by. Welcome to Schrodinger's conference call to review third quarter 2025 financial results.
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Tops Revenue Estimates
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to a loss of $0.52 per share a year ago.
Strength Seen in Schrodinger (SDGR): Can Its 13.8% Jump Turn into More Strength?
Schrodinger (SDGR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
